Anesthetic Depth and the Incidence of Emergence Agitation in Children Undergoing Strabismus Surgery

Sponsor
Seoul National University Bundang Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT02521259
Collaborator
(none)
68
1
12
5.7

Study Details

Study Description

Brief Summary

This study evaluates the association between the depth of general anesthesia and the occurrence of emergence agitation (EA). The investigators hypothesized that optimal level of anesthetic depth could decrease the incidence of EA in children undergoing strabismus surgery compared to the deep level of anesthetic depth.

Condition or Disease Intervention/Treatment Phase
  • Device: BIS

Detailed Description

EA is characterized by dissociated state of consciousness, in which the children are inconsolable, irritable, uncooperative, thrashing, crying, moaning or incoherent.

Several predisposing factors for EA include post-operative pain, rapid emergence from general anesthesia, use of volatile anesthetics, type and site of operation (usually head & neck surgeries), agitation on induction, airway obstruction, hyperthermia or hypothermia.

The effect of anesthetic depth on the EA has rarely been evaluated in pediatric population, even though postoperative delirium or postoperative cognitive dysfunction (POCD)corresponds to the EA identically.

In this study, the concentration of anesthetics was not managed on purpose to lower the BIS score. Patients were allocated to each group based on the result of average BIS score during the operation.

Study Design

Study Type:
Observational
Actual Enrollment :
68 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
The Correlation Between Anesthetic Depth and the Incidence of Emergence Agitation in Children Undergoing Strabismus Surgery
Actual Study Start Date :
Apr 1, 2015
Actual Primary Completion Date :
Mar 1, 2016
Actual Study Completion Date :
Apr 1, 2016

Arms and Interventions

Arm Intervention/Treatment
low Bispectral index (BIS) group

BIS range under 40

Device: BIS
BIS monitoring provides the patient's depth of consciousness, enables us to monitor safe, optimal anesthesia for each patient.

normal BIS group

BIS range from 40 to 60

Device: BIS
BIS monitoring provides the patient's depth of consciousness, enables us to monitor safe, optimal anesthesia for each patient.

Outcome Measures

Primary Outcome Measures

  1. the Pediatric Anesthesia Emergence Delirium (PAED) Score [30 minutes]

    Evaluating the Pediatric Anesthesia Emergence Delirium (PAED) score 3 times at the post-anesthetic care unit (PACU): when participant arrived at PACU, measure the PAED score (from 0 to 20; the higher score indicates the severer emergenct agitation) immediately and if the score is 10 or over 10, give the participant Fentanyl 1mcg/kg. Repeat checking the PAED score 2 times more with 15 minutes interval.

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years to 5 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • aged between 3 and 5 years

  • American Society of Anesthesiologists physical status I or II

Exclusion Criteria:
  • American Society of Anesthesiologists physical status over III,

  • any disease that could affect mental status

  • pre-existing forehead wound

Contacts and Locations

Locations

Site City State Country Postal Code
1 Seoul National University Bundang Hospital, department of Anesthesia and pain Seongnam Gyenggo-do Korea, Republic of 13620

Sponsors and Collaborators

  • Seoul National University Bundang Hospital

Investigators

  • Study Director: HYO SEOK NA, Seoul National University Bundang Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
LEE YEA JI, clinical professor, Seoul National University Bundang Hospital
ClinicalTrials.gov Identifier:
NCT02521259
Other Study ID Numbers:
  • B-1503-289-004
First Posted:
Aug 13, 2015
Last Update Posted:
Oct 21, 2019
Last Verified:
Sep 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Keywords provided by LEE YEA JI, clinical professor, Seoul National University Bundang Hospital
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Normal Bispectral Index (BIS) Group Low Bispectral Index (BIS) Group
Arm/Group Description Bispectral index (BIS) range from 40 to 60 BIS: BIS monitoring provides the patient's depth of consciousness, enables us to monitor safe, optimal anesthesia for each patient. BIS range under 40 BIS: BIS monitoring provides the patient's depth of consciousness, enables us to monitor safe, optimal anesthesia for each patient.
Period Title: Overall Study
STARTED 35 33
COMPLETED 34 28
NOT COMPLETED 1 5

Baseline Characteristics

Arm/Group Title Low Bispectral Index (BIS) Group Normal BIS Group Total
Arm/Group Description BIS range under 40 BIS: BIS monitoring provides the patient's depth of consciousness, enables us to monitor safe, optimal anesthesia for each patient. BIS range from 40 to 60 BIS: BIS monitoring provides the patient's depth of consciousness, enables us to monitor safe, optimal anesthesia for each patient. Total of all reporting groups
Overall Participants 28 34 62
Age (Count of Participants)
<=18 years
28
100%
34
100%
62
100%
Between 18 and 65 years
0
0%
0
0%
0
0%
>=65 years
0
0%
0
0%
0
0%
Sex: Female, Male (Count of Participants)
Female
15
53.6%
18
52.9%
33
53.2%
Male
13
46.4%
16
47.1%
29
46.8%
Race and Ethnicity Not Collected (Count of Participants)
Count of Participants [Participants]
0
0%

Outcome Measures

1. Primary Outcome
Title the Pediatric Anesthesia Emergence Delirium (PAED) Score
Description Evaluating the Pediatric Anesthesia Emergence Delirium (PAED) score 3 times at the post-anesthetic care unit (PACU): when participant arrived at PACU, measure the PAED score (from 0 to 20; the higher score indicates the severer emergenct agitation) immediately and if the score is 10 or over 10, give the participant Fentanyl 1mcg/kg. Repeat checking the PAED score 2 times more with 15 minutes interval.
Time Frame 30 minutes

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Low Bispectral Index (BIS) Group Normal BIS Group
Arm/Group Description BIS range under 40 BIS: BIS monitoring provides the patient's depth of consciousness, enables us to monitor safe, optimal anesthesia for each patient. BIS range from 40 to 60 BIS: BIS monitoring provides the patient's depth of consciousness, enables us to monitor safe, optimal anesthesia for each patient.
Measure Participants 28 34
T1 (on arrival PACU)
12.5
(5.0)
11.4
(5.4)
T2 (15 minutes after T1)
6.5
(1.3)
5.4
(3.4)
T3 (15 minutes after T2)
3.2
(2.0)
3.4
(2.5)

Adverse Events

Time Frame Adverse event data were collected every 6 months.
Adverse Event Reporting Description In this study, the concentration of inhalational agent was conventional in both group. We didn't manage the concentation intentionally to make BIS lower than 40 even in Low BIS Group. There were no adverse event and/or serious adverse event.
Arm/Group Title Low Bispectral Index (BIS) Group Normal BIS Group
Arm/Group Description BIS range under 40 BIS: BIS monitoring provides the patient's depth of consciousness, enables us to monitor safe, optimal anesthesia for each patient. BIS range from 40 to 60 BIS: BIS monitoring provides the patient's depth of consciousness, enables us to monitor safe, optimal anesthesia for each patient.
All Cause Mortality
Low Bispectral Index (BIS) Group Normal BIS Group
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/28 (0%) 0/34 (0%)
Serious Adverse Events
Low Bispectral Index (BIS) Group Normal BIS Group
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/28 (0%) 0/34 (0%)
Other (Not Including Serious) Adverse Events
Low Bispectral Index (BIS) Group Normal BIS Group
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/28 (0%) 0/34 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Dr. YEA JI LEE
Organization Seoul National University Bundang Hospital
Phone +821086307701
Email ladydaisy82@naver.com
Responsible Party:
LEE YEA JI, clinical professor, Seoul National University Bundang Hospital
ClinicalTrials.gov Identifier:
NCT02521259
Other Study ID Numbers:
  • B-1503-289-004
First Posted:
Aug 13, 2015
Last Update Posted:
Oct 21, 2019
Last Verified:
Sep 1, 2019